So, NP gives us a chance to find and verify the key targets for explaining how QTHX regulated the SOCS1/TLR4/NF-κB cell signalling pathway to treat NASH. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatohepatitis.